Statistical Research and Applications Branch National Cancer Institute Other Sites Contact Us Home Statistical Research and Applications Branch
skip navigation
Cancer.gov
Funding Opportunities in Biostatistics - Division of Cancer Control and Population Sciences SRAB
* About statfund.cancer.gov
* Funded Statistical Grants
* Statistical Study Sections
* Program Directors for the DCCPS Statistical Portfolio
* Special Funding Solicitations
* Application Forms and Instructions
* Other Funding Sites
* Articles Related to Funding at NIH
* Biostatistical Groups at NCI
   
Related Materials:
* Center for Scientific Review: Referral Procedures
* Cancer Intervention and Surveillance Modeling Network (CISNET)

Publications for CA088160

Publication Title
(click to view publication in PubMed)*
1.An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States
Am J Epidemiol 2004 Dec 1 ;160(11):1059-1069
2.Cluster-based network model for time-course gene expression data
Biostatistics 2007 Jul ;8(3):507-525
3.Combining longitudinal studies of PSA
Biostatistics 2004 Jul ;5(3):483-500
4.Discovering subpopulation structure with latent class mixed models
Stat Med 2002 Feb 15 ;21(3):417-429
5.Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends
J Natl Cancer Inst 2002 Jul 3 ;94(13):981-990
6.Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998
Urology 2002 Feb ;59(2):251-255
7.Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis
Cancer 2003 Aug 1 ;98(3):496-503
8.Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999
Urology 2004 Dec ;64(6):1171-1176
9.Risks of cancer and families
J Natl Cancer Inst 2005 Nov 2 ;97(21):1556-1557
10.Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer
Int J Radiat Oncol Biol Phys 2006 Oct 1 ;66(2):395-402
11.The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing
Stat Methods Med Res 2004 Dec ;13(6):421-442
12.Trends in treatment costs for localized prostate cancer: the healthy screenee effect
Med Care 2007 Feb ;45(2):154-159

ARP logo Surveillance Research Program
DCCPS
National Cancer Institute
DCCPS logo Division of Cancer Control &
Population Sciences

National Cancer Institute
Comments to: srab-web@nih.gov
Accessibility: Feedback Form
Privacy Policy & Disclaimers
Cancer.gov National Institutes of Health Department of Health and Human Services FirstGov.gov